|
Biotechnology Regulatory eService wins praise from independent users
Those who have already registered as members of the new Biotechnology Regulatory eService (BReS) have commented:
- 'This is just fabulous - we have a meeting tomorrow with a potential investor and it really helps put us in a stronger position.'
- 'I think your service is of terrific value.'
- 'I would like very much to subscribe to your newsletter. I was forwarded a copy and found it very useful and informative.'
BreS is a free one-to-one advice and regulatory news service offered by LGC with DTI support. It reflects the scientific scope of the Biotechnology Regulatory Atlas. Members can ask about the quality of measurements needed to fulfil product development and approval strategies, or about wider aspects of biotechnology, innovation and regulatory compliance.
Click here to register for BReS. Benefits include:
- confidential regulatory-technical advice (e.g. product purity, impurity profiling, quality control statistics, gene constructs, and the management of biological heterogeneity);
- confidential regulatory affairs support (e.g. product development strategy, due diligence, GMP compliance);
- the Biotechnology Regulatory Bulletin (A quarterly update focusing on the latest on legislative requirements and deadlines.).
The Biotechnology Regulatory Atlas is available from The Stationary Office (TSO). Click here for more information or phone 0870 600 5522.
|
|